J. Jiang

发表

3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.

K. Middleton, R. Perez-soler, Y. Ling, 1998, Cancer research.

Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals.

G. Bekesi, J. Jiang, 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individuals.

A. L. Goldstein, J. Roboz, M. Schlesinger, 1994, Clinical immunology and immunopathology.

Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.

J. Roboz, J. Holland, J. Strauchen, 1998, Cancer research.

Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.

H. Zhang, S. Wilk, J. Bekesi, 1997, Research in virology.

3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9.

L. Denner, Y. Ling, J. Roboz, 2000, Biochemical pharmacology.

Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.

J. Roboz, J. Holland, J. Bekesi, 1997, Cancer research.

Unique induction of p21WAF1/CIP1expression by vinorelbine in androgen-independent prostate cancer cells

D. Budman, A. Ferrari, L. G. Wang, 2003, British Journal of Cancer.

Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas.

J. Roboz, J. Holland, J. Bekesi, 1998, Anti-Cancer Drug Design.

3-Bromoacetylamino benzoylurea (3-BAABU), a new antimicrotubule cancericidal agent applied in cytogenetic analysis in hematology.

J. Holland, J. Bekesi, J. Jiang, 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Novel suicide ligands of tubulin arrest cancer cells in S-phase.

K. Middleton, Y. Ling, J. Bekesi, 1999, Neoplasia.

Phenotypic aberrations of CD3+ and CD4+ cells and functional impairments of lymphocytes at low-level occupational exposure to lead.

A. Fischbein, J. Roboz, J. Bekesi, 1993, Clinical immunology and immunopathology.

Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection.

P. Mason, J. Bekesi, F. Chu, 1992, Clinical immunology and immunopathology.

Phase I study of ON 01910.Na by 3-day continuous infusion (CI) in patients (pts) with advanced cancer.

L. Silverman, J. Roboz, T. Ohnuma, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autoantibody response to heat shock protein 70 in patients with heatstroke.

J. Jiang, H. Pan, T. Wu, 2001, The American journal of medicine.

Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.

J. Holland, L. Silverman, M. Schlesinger, 1996, Journal of clinical & laboratory immunology.

High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivo.

J. Roboz, J. Holland, G. Bekesi, 2001, Anticancer research.